Ons 17 apr / År 42 / Nr 1 2024

The fastest route in developing ideas into substantial industrial opportunities

The life science industry is dependent on close collaborations and secure relationships with frontline researchers. The Stockholm – Uppsala region is widely known as Sweden’s most prominent district in terms of innovations and research within the life science area.

Stockholm – Uppsala is the birth district of many of the world’s prime players dedicating their business to life science related activities. The region is a stronghold for research and development within a wide range of disciplines such as diagnostics, medical devices and pharmaceuticals.
Uppsala provides a platform for efficient and innovative networking between local and international life science companies of different sizes, and perhaps most importantly acts as a catalyst in the cooperation between industry and academia.
“It is our duty to market the developments and progress made by local researchers”, Ingrid Anderbjörk, Senior Advisor at the City of Uppsala, Executive office, explains. She continues: “The overall goal is to present opportunities for external parties to invest in our region. In order to do so we must create good practice and reliable communications between industrial parties and academic institutions for example”.
Anderbjörk has a clear mission: to facilitate a faster route for ideas to become industrial opportunities, and Stockholm – Uppsala provides a good infrastructure. More than 50 % of the Swedish life science industry is located in the region, and within one hour’s drive you will find six universities, three university hospitals, over 500 companies with over 20 000 employees and influential authorities such as the Swedish Medical Products Agency and the European Centre for Disease Prevention and Control, ECDC.

SciLifeLab – national infrastructure for molecular biosciences
There are several examples illustrating the comprehensive expertise of Uppsala’s life science cluster. On of the most outstanding is the Science for Life Laboratory (SciLifeLab), initiated by the Swedish government as an innovation and research centre focusing on large scale research in molecular biosciences and medicine. SciLifeLab is built up by two cooperating centres in Stockholm and Uppsala. The aim is to provide a national infrastructure for molecular biosciences, both nationally and globally.

Collaboration is the key
It is evident that collaboration and solid relationships are crucial factors for development within the life science field. The Uppsala University Hospital has initiated an innovation programme in cooperation with life science catalyst and coordinator UppsalaBIO, and the Swedish channel for investment, state-owned ALMI. “This pilot project aims to increase the flow of innovations from hospital staff, and link them to external parties in order to develop the innovation into a substantial product or service. Opportunities will also be offered for example medtech companies to test and verify new products through Innovation Akademiska”. Ingrid Anderbjörk concludes: “We are eager to see the upcoming results of our joint efforts”.